Pak Fah Yeow International Limited

239 BMG6873Y1176

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 09:08:07 18/06/2024 BST			5-day change	1st Jan Change
2.48 ^HKD	-0.80%		+1.22%	+40.11%

06-13	Pak Fah Yeow International Limited Approves a Special Final Dividend for the Year Ended 31 December 2023	CI
06-13	Pak Fah Yeow International Limited Approves a Final Dividend for the Year Ended 31 December 2023	CI

Pak Fah Yeow International Limited Approves a Special Final Dividend for the Year Ended 31 December 2023

June 13, 2024 at 11:04 am

Pak Fah Yeow International Limited approved a special final dividend of HK 8.2 cents per share for the year ended 31 December 2023.

Latest news about Pak Fah Yeow International Limited

Pak Fah Yeow International Limited Approves a Special Final Dividend for the Year Ended 31 December 2023	06-13	CI
Pak Fah Yeow International Limited Approves a Final Dividend for the Year Ended 31 December 2023	06-13	CI
Pak Fah Yeow International Limited Proposes Special Final Dividend for the Year Ended 31 December 2023, Payable on 12 August 2024	03-26	CI
Pak Fah Yeow International Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 August 2024	03-26	CI
Pak Fah Yeow International Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-26	CI
Pak Fah Yeow International Forecasts Attributable Profit to Triple in 2023	03-08	MT
Pak Fah Yeow International Limited Provides Earnings Guidance for the Year Ended 31 December 2023	03-07	CI
Pak Fah Yeow International Limited Appoints Gan Fook Yin, Anita as Member of Nomination Committee	12-07	CI
Pak Fah Yeow International Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 08 December 2023	30/08/23	CI
Pak Fah Yeow International Limited Announces Special Interim Dividend for the Year Ending 31 December 2023, Payable on December 8, 2023	30/08/23	CI
Pak Fah Yeow International Limited Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23	CI
Pak Fah Yeow to Swing to Profit in H1	07/07/23	MT
Pak Fah Yeow International Limited Provides Earnings Guidance for the Six Months Ending 30 June 2023	07/07/23	CI
Pak Fah Yeow International Limited Declares Special Dividend for the Year Ended 31 December 2022	07/06/23	CI
Pak Fah Yeow International Limited Declares Final Dividend for the Year Ended 31 December 2022	07/06/23	CI
Pak Fah Yeow International Limited Proposes Special Dividend for the Year Ended 31 December 2022 Payable on 11 August 2023	30/03/23	CI
Pak Fah Yeow International Limited Proposes Final Dividend for the Year Ended 31 December 2022 Payable on 11 August 2023	30/03/23	CI
Pak Fah Yeow International Limited Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23	CI
Pak Fah Yeow Expects Lower 2022 Profit	21/03/23	MT
Pak Fah Yeow International Limited Provides Earnings Guidance for the Year Ended 31 December 2022	17/03/23	CI
Pak Fah Yeow International Limited Announces Board Changes	30/09/22	CI
Pak Fah Yeow International Limited Declares Interim Dividend for the Year Ending December 31, 2022, Payable on or About December 9, 2022	31/08/22	CI
Pak Fah Yeow International Limited Reports Earnings Results for the Half Year Ended June 30, 2022	31/08/22	CI
Pak Fah Yeow International Limited Provides Earnings Guidance for the Six Months Ended 30 June 2022	23/08/22	CI
Pak Fah Yeow International Limited Approves Special Dividend for the Year Ended 31 December 2021	30/06/22	CI

Chart Pak Fah Yeow International Limited

Duration

Period

Chart Pak Fah Yeow International Limited

More charts

Pak Fah Yeow International Ltd is an investment holding company principally engaged in the manufacture and sale of healthcare products. The Company operates through three segments. The Healthcare segment is engaged in the manufacture and sales of healthcare products under the brand names of Hoe Hin products. The Property Investment segment is engaged in the investment in commercial, office, industrial and residential properties. The Treasury Investment segment is engaged in the equity and debt securities, mutual funds and dual currency investments businesses.

Sector

Pharmaceuticals

Calendar

27/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
PAK FAH YEOW INTERNATIONAL LIMITED	+40.11%	99.75M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.76%	43.54B
OTSUKA HOLDINGS CO., LTD.	+18.62%	21.51B
SANDOZ GROUP AG	+18.44%	15.34B
CIPLA LIMITED	+26.36%	15.12B
ZYDUS LIFESCIENCES LIMITED	+56.55%	13.37B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-14.94%	6.38B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.17%	5.36B

Generic Pharmaceuticals